Publications
-
Urtasun N, Vidal-Pla A, Perez-Torras S and Mazo A.
Human pancreatic cancer stem cells are sensitive to dual inhibition of IGF-IR and ErbB receptors
BMC Cancer . 15: 223-223. Number of citations: 16
-
Minami K, Shinsato Y, Yamamoto M, Takahashi H, Zhang S, Nishizawa Y, Tabata S, Ikeda R, Kawahara K, Tsujikawa K, Chijiiwa K, Yamada K, Akiyama S, Perez-Torras S, Pastor-Anglada M, Furukawa T and Yasuo T.
Ribonucleotide reductase is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells with dual resistant factors
JOURNAL OF PHARMACOLOGICAL SCIENCES . 127(3): 319-325. Number of citations: 39